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Abstracts / Urological Science 26 (2015) S50eS81S72carried at least one C allele at rs187238 had a 2.760efold risk of UCC.
However, the rs1946518 and rs187238 polymorphisms of the IL-18 gene
did not affect tumor stage among the UCC patients.
Conclusion: The rs187238 polymorphic genotypes of IL-18 might
contribute to the susceptibility of UCC and the synergic effect of smoking
was also demonstrated.
NDP086:
HEMATURIA WITH BLADDER TAMPONADE AND RENAL FAILURE DUE
TO GALLBLADDER CANCER METASTASIS
Ching-Ming Su, Chien-Yuan Wang, Hsiu-Nan Tsai, Wei-Che
Weng. Department of Urology, Kaohsiung Municiple United Hospital, Taiwan
Introduction: There are many possible causes of hematuria including:
urinary tract infection, urolithiasis, tumor in kidney or bladder, exercise,
drug, bleeding disorder or trauma. Herein we report a case of hematuria
with bladder tamponade due to gallbladder cancer metastasis
Case report: A 61-year-old women presented with gross hematuria,
nausea, vomiting to our ER for help. According to the statement of her, DM,
CRI, gallbladder stone, cancer post operation. Sonography revealed bladder
tamponade and left hydronephrosis. Due to poor condition, CT scan was
performed and revealed much bladder clot, left hydronephrosis, ascites
and favored carcinomatosis. Emergent cystoscopy removed blood and
bladder tumor was noted. TURBT was performed and pathology revealed
gallbladder cancer metastasis
NDP087:
PROGNOSTIC VALUE OF VISFATIN PROTEIN OVEREXPRESSION IN
UPPER TRACT UROTHELIAL CARCINOMAS IN TAIWAN
Hung-Lung Ke 1,3,5, Hui-Hui Lin 3,5, Wei-Ming Li 1,3,5,8, Ching-Chia
Li 1,3,5,7, Lin-Li Chang 1,4, Yi-Chen Lee 1,2, Chun-Nung Huang 1,3,5, Wen-
Jeng Wu 1,3,5,6. 1Graduate Institute of Medicine, Kaohsiung Medical
University, Kaohsiung, Taiwan; 2Department of Anatomy, Kaohsiung
Medical University, Kaohsiung, Taiwan; 3Department of Urology, Kaohsiung
Medical University, Kaohsiung, Taiwan; 4Department of Microbiology,
College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan;
5Department of Urology, Kaohsiung Medical University Hospital,
Kaohsiung, Taiwan; 6Department of Urology, Kaohsiung Municipal Hsiao-
Kang Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan;
7Department of Urology, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung
Medical University, Kaohsiung, Taiwan; 8 Pingtung Hospital, Department of
Health, Executive Yuan, Pingtung, Taiwan
Purpose: Visfatin, a newly discovered adipocytokine, is a pro-inﬂamma-
tory cytokine. This study aimed to evaluate the predictive value of visfatin
on prognosis of patients with upper tract urothelial carcinoma.
Materials andMethods: One-hundred and ﬁve patients (median age¼ 64,
range ¼ 24-84 years) were included in this study. Visfatin expression in
upper tract urothelial carcinoma tissues was analyzed by immunohisto-
chemistry. Visfatin expression was correlated with clinicopathologic var-
iables using the c2 test. The prognostic value of visfatin for recurrence-free
and cance-speciﬁc survival was evaluated by Kaplan-Meier estimates, and
the signiﬁcance of differences between curves was evaluated by the log-
rank test. Cox regression model was also used to evaluate the hazard ratios
of visfatin on survival.
Results: High visfatin expression in upper tract urothelial carcinoma tis-
sues was signiﬁcantly correlated with tumor stage (p ¼ 0.001), grade
(p ¼ 0.007) and p53 expression (p ¼ 0.07). High visfatin expression was
associated with poor recurrence-free and cancer-speciﬁc survival. Cox
regression analysis also revealed that visfatin is an independent predictor
of recurrence-free (HR ¼ 3.22, p ¼ 0.009) and cancer-speciﬁc survival
(HR ¼ 5.74, p ¼ 0.023).
Conclusion: Our ﬁndings indicated that higher visfatin expression is a
potential biomarker to predict patient survival. Further study is necessary
to investigate the molecular mechanisms of visfatin involved in the
cancerous processes of upper tract urothelial carcinoma.NDP088:
SIGNAL TRANSDUCERS AND ACTIVATORS OF TRANSCRIPTION 3 (STAT3)
EXPRESSION AND THE PROGNOSIS IN UPPER URINARY TRACT
UROTHELIAL CARCINOMA
Hung-Lung Ke 1,2,3, Szu-Han Chen 1,3, Hui-Hui Lin 2,3, Wei-Ming
Li 1,2,3,6, Ching-Chia Li 1,2,3,5, Hsin-Chih Yeh 1,2,3,4, Chun-Nung
Huang 1,2,3, Wen-Jeng Wu1,2,3,4. 1Graduate Institute of Medicine,
Kaohsiung, Taiwan; 2Department of Urology, College of Medicine,
Kaohsiung Medical University, Kaohsiung, Taiwan; 3Department of Urology,
Kaohsiung Medical University Hospital, Kaohsiung, Taiwan; 4Department of
Urology, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung Medical
University, Kaohsiung, Taiwan; 5Department of Urology, Kaohsiung
Municipal Ta-Tung Hospital, Kaohsiung Medical University, Kaohsiung,
Taiwan; 6 Pingtung Hospital, Department of Health, Executive Yuan,
Pingtung, Taiwan
Purpose: Signal transducers and activators of transcription (STATs) play an
important role in gene regulation, cell proliferation and differentiation.We
aimed to establish the relationship between STAT3 expression and the
prognosis of upper tract urothelial carcinoma (UTUC).
Materials and Methods: This study retrospectively reviewed 100 patients
with pathologically conﬁrmed UTUC at Kaohsiung Medical University
Hospital. We quantify the expressions of STAT3 in cancer cells by immu-
nohistochemistry method, and determine the clinicopathologic signiﬁ-
cance between expression of STAT3 and prognostic outcome in patients
with UTUC.
Results: High STAT3 expression was detected in 52% of whole UTUC pa-
tients. High STAT3 expression was associated with poor recurrence-free
(p ¼ 0.018) and overall survival (p ¼ 0.026). In the advanced cancer
(stageT3/T4), STAT3 expression is the only independent prognostic factor
for recurrence-free survival (hazard ratio ¼ 5.91, p ¼ 0.01) and cancer-
speciﬁc survival (hazard ratio ¼ 8.83, p ¼ 0.039).
Conclusion: In UTUC, the STAT3 can be a potential prognostic marker for
cancer recurrence and survival, especially in the advanced stage.
NDP089:
COMPARISON OF PARTIAL NEPHRECTOMY AND PERCUTANEOUS
RADIOFREQUENCY ABLATION FOR SMALL RENAL MASSES IN THE
MANNER OF PREOPERATIVE ASPECTS AND DIMENSIONS USED FOR
AN ANATOMICAL (PADUA) CLASSIFICATION
Wei-Ting Kuo, Lun-Hsiang Yuan, Yin-Shen Chen, Jen-Tai Lin, Jeng-Yu
Tsai, Chia-Cheng Yu, Tony T. Wu. Division of Urology, Department of
Surgery, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan, ROC
Purpose:We present our experience with the clinical feature, efﬁcacy and
outcome of comparison of partial nephrectomy and radiofrequency abla-
tion (RFA) for small renal tumors in the manner of Preoperative Aspects
and Dimensions Used for an Anatomical (PADUA) Classiﬁcation as a min-
imal invasive treatment in VGHKS
Materials and Methods: A total of 78 patients in 15 years with small renal
tumors were enrolled. We use Preoperative Aspects and Dimensions Used
for an Anatomical (PADUA) Classiﬁcation for renal tumor classiﬁcation and
compared PN (42 patients) and RFA (36 patients) with clinical outcome
(local recurrence-free, metastases-free, and overall survival rates), RFA
procedure (RFA needle, No. of treatment, Anesthesia, complication), renal
function deterioration after procedure and pathology report. We also use
clustered needle or switch mode control of RFA and D5W instillation for
separating bowel loop.
Results: The median value of the PADUA score was 7.5 (IQR: 7e9), which is
no signiﬁcant difference between two groups. Of the 56 cT1a patients, 32
underwent PN, 24 underwent RFA. In this cohort, local recurrence-free
survival, metastases-free survival were similar among the two treatments
(p¼ 0.53 / 0.46). Of the 22 cT1b patients, 10 patients underwent PN, and 12
patients were managed with RFA. In this cohort, local recurrence-free
survival (p ¼ 0.76) and metastases-free survival (p ¼ 0.51) were similar
between PN and RFA. In both the cT1a and cT1b groups, PN patients were
signiﬁcantly younger, with lower Charlson scores and had superior overall
survival (p < 0.001 for all). In the RFA group, all patients have been biopsy
Abstracts / Urological Science 26 (2015) S50eS81 S73before RFA and 22 been proved RCC. The number of RFA needle treatment
were signiﬁcantly correlated to PADUA score. 13 patients were under local
anesthesia, the other were under IVGA by anesthesiologist. Only one pa-
tient presented mild pneumothorax after RFA without intervention
treatment. Renal function deterioration after procedure did not reveal
clinical signiﬁcance. Tumor recurrence was recognized by CT scan in 3
patients during followup, who repeated RFA treatment without
recurrence.
Conclusion: For carefully selected patients, RFA represent a less inva-
sive alternative associated with less morbidity and fewer complications
and a promising treatment compared with partial nephrectomy. How-
ever, the long-term efﬁcacy of these approaches remains to be estab-
lished.LUTS
NDP090:
THE PROTECTIVE EFFECT OF EPIGALLOCATECHIN GALLATE ON
OXIDATIVE STRESS TRIGGERED THROUGH MITOCHONDRIA AND
ENDOPLASMIC RETICULUM IN A METABOLIC SYNDROME-INDUCED
BLADDER OVERACTIVITY RAT MODEL
Yung-Shun Juan 1,2,3,4, Yi-Lun Lee 4,5, Mei-Chin Lu 6,7, Wen-Jeng
Wu 1,2,3, Mei-Yu Jang 3, Wan-Ting Ho 1, Keh-Min Liu 8, Shu-Mien
Chuang 9. 1Department of Urology, Kaohsiung, Taiwan; 2Department of
Urology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan;
3Department of Urology, Kaohsiung Municipal Hsiao-Kang Hospital,
Kaohsiung, Taiwan; 4Graduate Institute of Medical Science, Kaohsiung,
Taiwan; 5Department of Urology, Chi-Shan Hospital, Department of Health,
Executive Yuan, Kaohsiung, Taiwan; 6Graduate Institute of Marine
Biotechnology, National Dong Hwa University, Pingtung 944, Taiwan;
7National Museum of Marine Biology & Aquarium, Pingtung 944, Taiwan;
8Department of Anatomy, College of Medicine, Kaohsiung, Taiwan;
9 Translational Research Center, Cancer Center, Kaohsiung Medical
University, Kaohsiung, Taiwan
Purpose: Long-term metabolic syndrome develops lower urinary tract
symptoms. The pathophysiology mechanism underlying the metabolic
syndrome associated with bladder dysfunction is still not clear. The major
aim of our study is to elucidate metabolic syndrome-induced bladder
dysfunction in association with oxidative stress triggered through mito-
chondria and endoplasmic reticulum (ER) in a metabolic syndrome
einduced bladder overactivity rat model. The other aim of the present
study is to elucidate the protective effect of epigallocatechin gallate (EGCG)
on metabolic syndrome einduced bladder overactivity.
Materials and Methods: Female Sprague-Dawley rats are divided into
control group, high fat high sugar (HFHS) diet group, HFHS diet with
bilateral ovariectomy (OVX) (HFHS +OVX) group, HFHS diet with bilateral
OVX and EGCG treatment (HFHS+OVX+EGCG) group, and HFHS diet with
EGCG (HFHS+EGCG) group, respectively. Cystometry (CMG) and mictu-
rition frequency/volume studies were recorded for bladder voiding
function. The terminal deoxynucleotidyl transferase dUTP nick-end la-
beling (TUNEL) assay was performed to evaluate the distribution of
apoptotic cells. Western blot was carried out to examine the expressions
of interstitial ﬁbrosis markers, muscarinic receptors (M2 and M3),
oxidative stress markers, endoplasmic reticulum stress markers (GRP78,
CHOP, caspase-12), apoptosis-associated proteins, and the subunits of
mitochondrial respiratory complexes. The antioxidant enzymes,
including superoxide dismutase and catalase, were investigated by real-
time PCR.
Results: The HFHS diet with OVX treated rats displayed bladder over-
activity. Bladder contractility was considerably decreased in HFHS with
OVX group in response to electric ﬁeld, carbachol, and KCl stimulation as
compared with those in the control group. Such bladder dysfunction was
accompanied by a signiﬁcant increase in oxidative stress markers, ER-
associated oxidative stress proteins, apoptosis-associated proteins, and the
subunits of mitochondrial respiratory complexes. Conversely, the mRNA
expressions of antioxidant enzymes Mn-SOD, Cu/Zn-SOD and catalase
were also decreased after long-term HFHS treatment with/without OVX.However, EGCG treatment can improve the extent of oxidative stress and
lessen bladder hyperactivity.
Conclusion: HFHS combined with OVX enhanced the generation of
oxidative stress mediated through mitochondria- and ER-dependent
pathways, and consequently attributed to bladder apoptosis, whereas
EGCG treatment could eliminate these oxidative stress and reverse bladder
dysfunctions.
NDP091:
FUNCTIONAL BLADDER CAPACITY CORRELATES TO SEVERITY OF
SYMPTOMS IN PATIENTS WITH INTERSTITIAL CYSTITIS/PAINFUL
BLADDER SYNDROME
Hui-Ying Liu, Yao-Chi Chuang. Division of Urology, Kaohsiung Chang Gung
Memorial Hospital, Chang Gung University, College of Medicine, Taiwan
Purpose: To investigate the correlation between functional bladder ca-
pacity and the pain scale, and clinical symptoms in patients with inter-
stitial cystitis/painful bladder syndrome (IC/PBS).
Materials and Methods: A retrospective study of 30 patients with symp-
toms of IC/PBS were included. Functional bladder capacity was detected
according to 3-day voiding diary. Bladder hydrodistention were performed
under intravenous sedation or general anesthesia. A self-administered
questionnaire containing pain and urgency visual analogue scale (VAS),
O'Leary-Sant Symptom and Problem Indexes (including Interstitial Cystitis
Symptoms Index (ICSI) and Interstitial Cystitis Problem Index (ICPI)) were
obtained. The effects of hydrodistensionwere evaluated by Global Response
Assessment (GRA). A two-sample t test was performed to identify the dif-
ferences of continuous variables between the two groups with functional
bladder capacity of> 350ml and 350ml, and simple logistic regressionwas
applied to assess functional bladder capacitywithpain scale, symptomscore,
age, and bladder capacity in hydrodistention. The p value <0.05 was
considered to be statistically signiﬁcant. Statistical analyses were performed
using SPSS 20.0 statistics software (SPSS Inc., Chicago, IL).
Results: The baseline character has no signiﬁcant difference between two
groups (functional bladder capacity of > 350ml and  350ml) in age, pain
and urgency VAS, ICSI, ICPI, or post-voiding residual urine amount. There is
a trend of higher pain scale and symptom score as functional bladder ca-
pacity decreased. Furthermore, mean urgency in 3-day voiding diary,
bladder capacity on hydrodistention, and GRA showed statistically sig-
niﬁcant difference between two groups.
Conclusion: Functional bladder capacity correlates with pain scale and
symptom scores. The group of functional bladder capacity > 350ml has
larger bladder capacity in hydrodistention and signiﬁcantly symptoms
improvement after hydrodistension.Urolithiasis
NDP092:
CHANGE OF OXIDATIVE STRESS BEFORE AND AFTER ESWL FOR
PATIENTS WITH URETERAL STONE
Saint Shiou-Sheng Chen 1,2, Allen W. Chiu 1,2. 1Department of Urology,
National Yang-Ming University School of Medicine; 2Division of Urology,
Taipei City Hospital Renai Branch, Taipei, Taiwan
Purpose: To evaluate the change of oxidative stress before and after
extracorporeal shock wave lithotripsy (ESWL) for patients with ureteral
stone.
Materials and methods: Forty patients with ureteral stone and receiving
ESWLwere recruited in this study. The parameters for comparison included
severity of hydronephrosis (mild, moderate and severe), stone size, shock
wave numbers and KV, age, and bodymass index (BMI). The oxidative stress
and antioxidant capacity were evaluated by measuring malondialdehyde
(MDA), mitochondrial DNA (mtDNA) copy number and total capacity of
antioxidants (TOA) in the blood. The data were correlated with serum
creatinine, which were measured before and immediately after ESWL in all
patients. Malondialdehyde (MDA), one of the lipid peroxidation products, in
blood plasma was measured by reaction with a chromogenic regent
